Gene Expression Fingerprint of Uterine Serous Papillary Carcinoma
Author Information
Author(s): Santin A D, Zhan F, Cane' S, Bellone S, Palmieri M, Thomas M, Burnett A, Roman J J, Cannon M J, Shaughnessy J Jr, Pecorelli S
Primary Institution: University of Arkansas for Medical Sciences
Hypothesis
This study aims to identify genes with a differential pattern of expression between uterine serous papillary carcinoma (USPC) and normal endometrial cells (NEC) for the development of novel diagnostic and therapeutic markers.
Conclusion
The study identified multiple novel molecular markers for USPC that could lead to new type-specific therapies.
Supporting Evidence
- 139 genes were found to be upregulated in USPC compared to normal endometrial cells.
- 390 genes were downregulated in USPC compared to normal endometrial cells.
- Claudin-4 was validated as a potential therapeutic marker through immunohistochemical analysis.
- USPC showed high sensitivity to Clostridium perfringens enterotoxin in vitro.
Takeaway
Researchers looked at the genes in aggressive uterine cancer cells and found new markers that could help diagnose and treat this type of cancer better.
Methodology
The study used oligonucleotide microarrays to analyze gene expression in 10 primary USPC cultures and five normal endometrial cells.
Participant Demographics
[{"age":65,"race":"White","stage":"IV B"},{"age":75,"race":"Afro-American","stage":"III C"},{"age":75,"race":"Afro-American","stage":"IV A"},{"age":59,"race":"White","stage":"IV A"},{"age":59,"race":"White","stage":"III C"},{"age":62,"race":"Afro-American","stage":"IV B"},{"age":63,"race":"Afro-American","stage":"III C"},{"age":61,"race":"Afro-American","stage":"III C"},{"age":78,"race":"White","stage":"III C"},{"age":64,"race":"Afro-American","stage":"IV A"}]
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website